PT
Menu
Search
Sections
Home
News
Analysis
Features
Comment & Opinion
Projects
Data Insights
Sectors
Clinical Trials
Drug Manufacturers
Therapy Area
Cardiovascular
Central Nervous System
Immunology
Infectious Disease
Oncology
Respiratory
Pricing and Market Access
Themes
Artificial Intelligence
Corporate Governance
Cloud
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Events
Reports
Premium Insights
Excellence Awards
Innovation Rankings
Magazine
Newsletters
GlobalData
About us
Advertise With Us
Contact Us
Our Marketing Solutions
GlobalData Reports
Visit GlobalData
From Our Partners
Optimizing Cell & Gene Therapy Processes
Collaboration and Expertise in Contract Analytical Chemistry
A new generation of CDMO services
Accelerating Biopharmaceutical Innovation
Precision medicine and digital health innovation for disease diagnosis, care and treatment
Enabling process intensification in biopharma manufacturing
The next chapter of clinical trial services
Putting quality first in the pharma supply chain
Pharmaceutical Grade Silicone Manufacturer
Maximising molecule potential
News
Analysis
Sections
Features
Comment & Opinion
Projects
Data Insights
Latest
KRAS inhibitors: The next frontier beckons
Tracking the opioid lawsuit settlements amidst calls for oversight
OCT Europe: Unless everyone is benefiting, what is the point?
Sectors
Sections
Clinical Trials
Drug Manufacturers
Therapy Area
Pricing and Market Access
Latest
AstraZeneca selects new heart failure target with BenevolentAI
Uniquity Bio launches to focus on immunology and inflammation
Takeda’s dengue vaccine obtains WHO prequalification
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Foreign Direct Investment
Latest
Orano Med’s Alpha Therapy Laboratory (ATLab), Onnaing, France
Novo Holdings-backed Commit launches with $17.2m in seed funding
Rakovina expands collaborations to leverage AI platform
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
BioNTech reports net loss of €315.1m in Q1 2024
Moderna reports $1.2bn net loss in Q1 2024
Pfizer’s reported net income declines 44% in Q1 2024
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Latest
Podcast #2: Doing Digital Deals in Life Sciences | Information Governance
Oral solid dosage manufacturing companies, equipment and market
Four ways the vaccine rush will define infectious disease trends for CROs in 2024
Events
Buy Reports
Newsletters
PT